- Rs117648444 nonsynonymous variant in INFL4 gene impacts on HCV RNA decline during the first 4 weeks of Pegylated Interferon and Ribavirin therapy in HCV-1 IL28B rs12979860 CT/TT patientsGalmozzi Enrico; Aghemo Alessio; Degasperi Elisabetta; D'Ambrosio Roberta; Soffredini Roberta; Grassi Eleonora; De Nicola Stella; Colombo Massimo64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, 2013-11-01 To 2013-11-05.
- Rapid and sharp decline in hepatitis C virus upon monotherapy with NS3 protease inhibitor, ACH-1625Atul Agarwal; Bao Zhang; Elizabeth Olek; Heather Robison; Lisa Robarge; Milind DeshpandeAntiviral Therapy, 2012, 17(8): 1533-1539.
- Protease-Inhibitor (PI) Triple Therapy (TT) in Mildly Decompensated Cirrhotics: Predictors of Treatment Discontinuation, Worsening Decompensation and Sustained Virologic ResponseSaxena Varun; Yee Helen S; Catalli Lisa; Wayne Elizabeth M; Chua Joshua; Monto Alexander; Terrault Norah64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, 2013-11-01 To 2013-11-05.
期刊论文
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
2阅读
